$2.63
At close: Apr 14 EDT
$2.25
-0.38-14.45%
Pre-Market: 4:05 AM EDT
Comments
Loading...
BioNexus Gene Lab Earnings Estimates, EPS & Revenue | NASDAQ:BGLC | Benzinga
BioNexus Gene Lab reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 15
EPS
$-0.017
Quarterly Revenue
$2.63M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$9.26M
Analyze the earnings history of BioNexus Gene Lab using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BGLC | BioNexus Gene Lab | -$0.02 | — | — | — | $2.38M | — | — | — | 05/14/2025 | Get Alert |
| BGLC | BioNexus Gene Lab | — | — | — | — | — | — | — | — | 04/25/2025 | Get Alert |
| BGLC | BioNexus Gene Lab | -$0.16 | — | -$0.02 | — | $2.55M | — | $2.63M | — | 11/15/2024 | Get Alert |
| BGLC | BioNexus Gene Lab | -$0.04 | — | $0.01 | — | $2.57M | — | $1.98M | — | 08/14/2024 | Get Alert |
| BGLC | BioNexus Gene Lab | -$0.01 | — | -$0.02 | — | $2.38M | — | $2.38M | — | 05/15/2024 | Get Alert |
BioNexus Gene Lab (BGLC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
BioNexus Gene Lab (BGLC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is BioNexus Gene Lab (NASDAQ:BGLC) reporting earnings?
BioNexus Gene Lab (BGLC) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 15, 2024 for Q3.
What were the latest earnings per share (EPS) for BioNexus Gene Lab (NASDAQ:BGLC)?
The Actual EPS was $-0.02, which missed the estimate of $0.00.
What were BioNexus Gene Lab’s (NASDAQ:BGLC) revenues?
The Actual Revenue was $2.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.